China's vaccine gambit
Science's COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation Beijing-based Sinovac, which makes a COVID-19 vaccine from inactivated virus, has efficacy trials underway in Brazil, Turkey, and Indonesia—but not in China. PHOTO: REUTERS/THOMAS PETER The first people in the world to receive a COVID-19 vaccine were not part of a clinical trial. No TV stations or newspapers covered the historic event. No company issued a statement. On 29 February, less than 2 months after the world awakened to the threat of the new disease, virologist Chen Wei, a major genera...
Source: sciencemag.org